The purpose of the study was to demonstrate the antimicrobial property of integrating taurolidine, a taurine derivative, into the matrix of two types of monofilament fibers to simulate sutures with e-caprolactone (the major component of Monocryl) and p-dioxanone (PDS II).
The purpose of the study was to demonstrate the antimicrobial property of integrating taurolidine, a taurine derivative, into the matrix of two types of monofilament fibers to simulate sutures with e-caprolactone (the major component of Monocryl) and p-dioxanone (PDS II).
Taurolidine was successfully loaded at 2,6 and 10% by weight throughout the matrix of the fibers. 400 ul of early phase Pseudomonas aeruginosa (PAO1), the Staphylococcus epidermidis (S.epi 35984), and the multidrug resistant Staphylococcus aureus strain SA BAA-44) were plated separately into square plates. 200 ul of each were introduced into 25cmX25cm plates. Four pieces of each fiber were individually placed in the plates. The fibers tested were tauroldine loaded at 2, 6 and 10% dispersed in poly e-caprolactone and 2, 6, and 10% dispersed in p-dioxanone. After 24 hours of exposure the zone of Inhibition surrounding each fiber sample was measured in mm. In order to demonstrate quantitative bacteria kills with living microorganisms, each of the fibers were placed in 12 well bottom culture discs that had 1 ml Tryptic Soy Buffer containing 100 ul of Early Phase Culture of each of the 3 bacteria: Pseudomonas aeruginosa (PAO1), Staphylococcus epidermidis (S.epi 35984) and multidrug resistant Stapylococcus aureus strain SA BAA-44). After 24 hours of exposure, kills were measured for each micro-organism tested using a quantitative analysis.
Results from the zone of inhibition study revealed a statistically significant increase in the zone of inhibition, as measured in mm, of all three bacteria tested in 6% and 10% taurolidine loaded e-carolacone fibers and in 2%, 6% and 10% taurolidine loaded p-dioxanone fibers versus control fibers containing 0% taurolidine. Quantitative determination of Pseudomonas aeruginosa bacteria showed total kills for fibers that contained 6% or greater taurolidine in e-caprolactone fibers. Measurements for Stapylococcus aureus total kills were observed for all the e-caprolactone fibers that contained 2% or greater taurolidine and 6% or greater taurolidine in p-dioxanone fibers. Quantitative analysis of Staphylococcus epidermidis cultures demonstrated total bacteria kills for fibers containing 6% or greater taurolidine in e-caprolactone.
Taurolidine loaded fibers resist growth of bacterial in the vicinity of fibers as evidenced by zone of inhibition studies. Taurolidine loaded fibers have the ability to kill representative microorganisms that have great clinical significance. Taurolidine is an effective anti-microbial, non anti-biotic, where organisms are unlikely to develop resistance. 
Generation of a Novel

METHODS:
We developed a proprietary scaffold made from heparin and collagen containing recombinant interleukin 10 (IL 10). To characterize the release profile of IL 10 from the scaffolds, we indirectly assessed the amount of IL 10 in solution at ten time points using enzyme linked immunosorbent assays (ELISA). The absorptive properties of the scaffold were determined by swelling studies in phosphate buffered saline (PBS) at 37ºC. Surface microstructures of the scaffolds after being cross linked with glutaraldehyde were observed under scanning electron microscope (SEM). Monocytes isolated from the bone marrow of mice were differentiated into macrophages after 7 days in culture with macrophage colony stimulating factor (M CSF) and seeded onto hydrated IL 10 scaffolds. Scaffolds were then delivered onto full thickness splinted excisional wounds in mice to be polarized in vivo. We assessed wound size and healing progression with digital photographs. After wound closure, tissue was harvested for histologic, gene expression, and cellular analyses.
RESULTS:
The release profile demonstrated peak release of 35.5 ng/ul of IL 10 at 4 hours with a concentration of at least 18.7 ng/ul IL 10 maintained for 48 hours. The scaffolds reached full swelling in PBS within 15 minutes with a swelling ratio of 16.53. Gene expression analysis confirmed that macrophages seeded onto IL 10 scaffolds were CONCLUSION: Our results demonstrate that our novel proprietary scaffold can polarize macrophages to the M2 phenotype and deliver supra physiologic levels of macrophages to wounds to significantly accelerate wound healing in the absence of adverse effects on scar size and quality. Polarizing macrophages on a scaffold in vivo minimizes time in cell culture and is a desirable method for simultaneous directed differentiation and cell delivery. With further studies, this could prove to be a novel therapeutic for wound regeneration.
